BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -50.0% | 21 | -55.3% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 47 | -14.5% | 0.00% | – |
| Q1 2022 | $6,000 | -70.0% | 55 | -63.1% | 0.00% | – |
| Q4 2021 | $20,000 | +1900.0% | 149 | +1046.2% | 0.00% | – |
| Q2 2021 | $1,000 | -99.2% | 13 | -99.1% | 0.00% | -100.0% |
| Q4 2020 | $121,000 | -46.9% | 1,413 | -59.7% | 0.00% | -50.0% |
| Q3 2020 | $228,000 | +13.4% | 3,509 | +27.5% | 0.00% | 0.0% |
| Q2 2020 | $201,000 | +18.2% | 2,752 | -44.8% | 0.00% | 0.0% |
| Q1 2020 | $170,000 | -37.3% | 4,984 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $271,000 | – | 4,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |